“…Under continued dysregulated glucometabolic conditions [10,13,14], the hypercaloric nutrient intake promoted by the db/db mutation establishes a systemic hypertriglyceridemia which compromises peripheral tissue metabolic support [5,11], including the recognized disruption of normal cytoarchitecture and cellular glucose metabolism [10,13,14] by progressive hypercytolipidemia [5,11,15]. In response to chronic hypercaloric (glucose) and lipid sequestration rates, premature neuronal degeneration [16,17], hepatic lipoatrophy [10], pancreatic islet B-cell insulin degranulation and lipolipoidosis [2,11,18,19], renal cytoadiposity and glomerular filtration compromise [20,21], vascular endothelial disruption [3,15] as well as pronounced reproductive tract atrophy and sterility [3,4,[22][23][24] are recognized consequences of the chronic response to the metabolic disturbances induced by expression of the db/db mutation [5]. Ultimately, the widespread tissue involution promoted by these nonhomeostatic DOS indices results in premature pancreatic islet B-cell hyperlipidemia, islet dissolution, depressed insulin synthesis and secretion rates, as well as peripheral tissue glucometabolic dysregulation coincident with pancreatic lipoatrophy and a contracted life span in these mutants [5,11].…”